Matthew P Hardy

5PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromoleculesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Engineered Trivalent Human IgG1-Fc Proteins for Potent Complement Inhibition.

|Jun 26, 2026
In Vivo Efficacy of an Inhibitor of Complement and FcRn in Models of Glomerulonephritis and Collagen-Induced Arthritis Using Human C2 Knock-In Mice.

|Mar 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn.

Sandra Wymann, Rodrigo A V Morales, Wei Hong Toh

|Oct 28, 2023
The Molecular Mechanisms of Complement Receptor 1-It Is Complicated.

Matthew P Hardy, Mariam Mansour, Tony Rowe

|Apr 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.

Sandra Wymann, Marcel Mischnik, David Leong

Pageof 1

Frequent Collaborators

1 joint publications

Jenny Chia

1 joint publications

Michael A Gorman

1 joint publications

Michael W Parker

1 joint publications

Ian K Campbell